The regional oncology center in Sverdlovsk successfully uses a new method of combined treatment for patients with stage III lung tumors and a genetic mutation in PD-L1. The method has already been included in the clinical guidelines of the Ministry of Health of the Russian Federation, according to the region's information policy department.
The approach combines drugs and immunotherapy before and after surgery, as well as the most gentle surgical intervention.
"The uniqueness of surgical treatment in such patients is that, against the background of pre-surgical treatment, the structure of the lung tissue and blood vessels is flammable, so the intervention must be carried out using jewelry. The choice is made in favor of video-assisted (low traumatic) thoracoscopy," explained Maxim Rudenko, Head of the Thoracic Oncology Department at SOOD.
Professor and Dim Pischik, head of the thoracic surgery center at Sokolov Clinical Hospital No. 122 (St. Petersburg), came to Yekaterinburg to demonstrate the technique. During the demonstration operation, the doctors confirmed the effectiveness of the preoperative treatment: the tumor in the bronchus was significantly reduced, which made it possible to remove it in a low-traumatic manner and preserve lung functions. The patient has already recovered and is undergoing the next course of chemoimmunotherapy.